Optimization of a Modular Nanotransporter Design for Targeted Intracellular Delivery of Photosensitizer

Author:

Alieva Rena T.1,Ulasov Alexey V.1ORCID,Khramtsov Yuri V.1,Slastnikova Tatiana A.1,Lupanova Tatiana N.1ORCID,Gribova Maria A.12,Georgiev Georgii P.1,Rosenkranz Andrey A.12ORCID

Affiliation:

1. Laboratory of Molecular Genetics of Intracellular Transport, Institute of Gene Biology of Russian Academy of Sciences, 34/5 Vavilov St., 119334 Moscow, Russia

2. Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskie Gory St., 119234 Moscow, Russia

Abstract

Modular nanotransporters (MNTs) are drug delivery systems for targeted cancer treatment. As MNTs are composed of several modules, they offer the advantage of high specificity and biocompatibility in delivering drugs to the target compartment of cancer cells. The large carrier module brings together functioning MNT modules and serves as a platform for drug attachment. The development of smaller-sized MNTs via truncation of the carrier module appears advantageous in facilitating tissue penetration. In this study, two new MNTs with a truncated carrier module containing either an N-terminal (MNTN) or a C-terminal (MNTC) part were developed by genetic engineering. Both new MNTs demonstrated a high affinity for target receptors, as revealed by fluorescent-labeled ligand-competitive binding. The liposome leakage assay proved the endosomolytic activity of MNTs. Binding to the importin heterodimer of each truncated MNT was revealed by a thermophoresis assay, while only MNTN possessed binding to Keap1. Finally, the photodynamic efficacy of the photosensitizer attached to MNTN was significantly higher than when attached to either MNTC or the original MNTs. Thus, this work reveals that MNT’s carrier module can be truncated without losing MNT functionality, favoring the N-terminal part of the carrier module due to its ability to bind Keap1.

Funder

Russian Science Foundation

Publisher

MDPI AG

Reference74 articles.

1. Molecular Targeted Therapy: Treating cancer with specificity;Lee;Eur. J. Pharmacol.,2018

2. Targeted drug delivery strategies for precision medicines;Manzari;Nat. Rev. Mater.,2021

3. The future of peptide-based drugs;Craik;Chem. Biol. Drug Des.,2013

4. Trends in peptide drug discovery;Muttenthaler;Nat. Rev. Drug Discov.,2021

5. The evolution of commercial drug delivery technologies;Vargason;Nat. Biomed. Eng.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3